Detail akcie Kalbe Farma online

Business Summary: PT Kalbe Farma Tbk is an Indonesia-based company, which is engaged in the development, manufacturing and trading of pharmaceutical products, including human medicines and consumer health products. Its business divisions include Prescription Pharmaceutical, Consumer Health Division, Nutritional, and Distribution and Logistic divisions. The Prescription Pharmaceuticals division provides a range of products for all groups, from unbranded generic drugs for the mass-market segment, to branded generics and licensed drugs. The Consumer Health division's product portfolio spans from over-the-counter (OTC) drugs and energy drinks to a selection of ready-to-drink healthy beverage products. The Nutritional division manages a range of nutritional products, comprising powdered milk products for all age segments. It also offers a selection of non-milk nutritional products. The Distribution and Logistics Division operates the distribution coverage for pharmaceuticals products in Indonesia.
Financial Summary: BRIEF: For the three months ended 31 March 2025, Kalbe Farma Tbk PT revenues increased 6% to RP8.845T. Net income increased 12% to RP1.077T. Revenues reflect Prescription Pharmaceutical segment increase of 13% to RP2.481T, Consumer Health segment increase of 9% to RP1.36T, Domestic segment increase of 4% to RP8.308T, Export segment increase of 41% to RP537.73B. Net income benefited from Interest income increase of 26% to RP50.44B (income).